tolvaptan accord
accord healthcare s.l.u. - Толваптан - niewłaściwy zespół adh - leki moczopędne, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).
valsartan hct – 1a pharma 160 mg + 12,5 mg tabletki powlekane
1a pharma gmbh - valsartanum; hydrochlorothiazidum - tabletki powlekane - 160 mg + 12,5 mg
valsartan hct – 1a pharma 80 mg + 12,5 mg tabletki powlekane
1a pharma gmbh - valsartanum; hydrochlorothiazidum - tabletki powlekane - 80 mg + 12,5 mg
valsartan hct – 1a pharma 320 mg + 25 mg tabletki powlekane
1a pharma gmbh - valsartanum; hydrochlorothiazidum - tabletki powlekane - 320 mg + 25 mg
co-dipper 80 mg + 12,5 mg tabletki powlekane
sandoz gmbh - valsartanum + hydrochlorothiazidum - tabletki powlekane - 80 mg + 12,5 mg
co-dipper 160 mg + 12,5 mg tabletki powlekane
sandoz gmbh - valsartanum + hydrochlorothiazidum - tabletki powlekane - 160 mg + 12,5 mg
co-dipper 160 mg + 25 mg tabletki powlekane
sandoz gmbh - valsartanum + hydrochlorothiazidum - tabletki powlekane - 160 mg + 25 mg
co-dipper 320 mg + 25 mg tabletki powlekane
sandoz gmbh - valsartanum + hydrochlorothiazidum - tabletki powlekane - 320 mg + 25 mg
co-dipper 320 mg + 12,5 mg tabletki powlekane
sandoz gmbh - valsartanum + hydrochlorothiazidum - tabletki powlekane - 320 mg + 12,5 mg
valsartan hct – 1a pharma 320 mg + 12,5 mg tabletki powlekane
1a pharma gmbh - valsartanum; hydrochlorothiazidum - tabletki powlekane - 320 mg + 12,5 mg